Dash Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DASH PHARMS, and what generic and branded alternatives to DASH PHARMS drugs are available?
DASH PHARMS has eighteen approved drugs.
Summary for Dash Pharms
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 14 |
| NDAs: | 18 |
Drugs and US Patents for Dash Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dash Pharms | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 091537-003 | Mar 30, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Dash Pharms | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 091537-002 | Mar 30, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Dash Pharms | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | SOLUTION;INTRAVENOUS | 206074-001 | Nov 24, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
